Stock-based Compensation - Schedule of Stock Options Activity (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
Dec. 31, 2022	Dec. 31, 2021
Number of Options
Beginning Balance (in shares)	15,274
Granted (in shares)	2,766
Exercised (in shares)	(333)
Cancelled/forfeited (in shares)	(552)
Ending Balance (in shares)	17,155	15,274
Vested and expected to vest at end of period (in shares)	17,153
Exercisable at end of period (in shares)	10,582
Weighted- Average Exercise Price
Beginning Balance (in dollars per share)	$ 10.47
Granted (in dollars per share)	14.15
Exercised (in dollars per share)	1.52
Cancelled/forfeited (in dollars per share)	13.97
Ending Balance (in dollars per share)	11.13	$ 10.47
Vested and expected to vest at end of period (in dollars per share)	11.13
Exercisable at end of period (in dollars per share)	$ 9.85
Weighted- Average Remaining Contractual Life (in Years)	7 years 1 month 6 days	8 years
Vested and expected to vest at end of period, term	7 years 1 month 6 days
Exercisable at end of period, term	6 years 4 months 24 days
Aggregate Intrinsic Value	$ 3,698	$ 97,094
Vested and expected to vest at end of period	3,698
Exercisable at ending period	$ 3,669

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.